Welcome to our dedicated page for Zepp Health Corporation news (Ticker: ZEPP), a resource for investors and traders seeking the latest updates and insights on Zepp Health Corporation stock.
Zepp Health Corporation (NYSE: ZEPP) drives innovation at the intersection of wearable technology and digital health solutions. This news hub provides investors and industry professionals with essential updates on the company's advancements in smart health monitoring, strategic partnerships, and market leadership.
Access official press releases covering earnings reports, product launches (including Amazfit devices), technology collaborations, and operational developments. Our curated collection offers timely insights into ZEPP's proprietary health platforms, AI-driven innovations, and global expansion efforts within the $200B+ wearable technology sector.
Key updates include financial performance disclosures, R&D breakthroughs in biometric sensors, strategic alliances with health tech leaders, and regulatory milestones. The resource serves both casual observers tracking consumer wearable trends and professional analysts monitoring the competitive digital health landscape.
Bookmark this page for streamlined access to verified information about ZEPP's initiatives in personal wellness technology, without promotional bias or speculative commentary. Refresh regularly to stay current with developments impacting the company's position in global markets.
Zepp Health Corporation (NYSE: ZEPP) filed its annual report on Form 20-F for the fiscal year ending December 31, 2022, with the U.S. Securities and Exchange Commission. The report details the company’s performance as a leader in cloud-based healthcare services and smart wearable technology. The 2022 filing highlights that Zepp Health shipped 20 million units in smart health devices, reinforcing its position as a global leader in the sector. Shareholders can request free hardcopies of the report by contacting the company directly.
Founded in 2013, Zepp Health was known as Huami Corp. until its name change on February 25, 2021. The company continues to innovate with AI chips and biometric sensors aimed at enhancing health technology.
Zepp Health Corporation (NYSE: ZEPP) reported Q4 2022 revenues of RMB1.1 billion (US$155.4 million), a 35.5% decrease from Q4 2021, primarily due to a 65.5% drop in Mi Band sales. The company recorded a net loss of RMB75.5 million, contrasting with a net income of RMB36.3 million a year earlier. However, self-branded products saw a 28.5% quarter-over-quarter revenue growth and accounted for 77.4% of total revenues. Gross margin improved to 20.7%, driven by optimized product offerings. Looking ahead, Zepp anticipates Q1 2023 revenues between RMB0.60 billion and RMB0.75 billion, reflecting market uncertainties and sales conditions.
Amazfit, a brand owned by Zepp Health (NYSE: ZEPP), launched the Amazfit T-Rex Ultra, a premium outdoor GPS smartwatch designed for extreme conditions. This watch features a rugged design with 316L stainless steel, capable of operating in temperatures as low as -30℃ and maximizing visibility with a 1,000 nits AMOLED display. It boasts enhanced GPS tracking, a battery life of up to 20 days, and can support over 160 sports modes, including unique activities like freediving and skydiving. Priced from $399.99, the T-Rex Ultra targets adventure enthusiasts seeking advanced training features and eco-friendly design.
Amazfit, a prominent smart wearables brand under Zepp Health (NYSE: ZEPP), has launched the Amazfit GTR Mini, a compact smartwatch featuring a 42mm design, 14-day battery life, and over 120 sports modes. The sleek device weighs only 24.6g and includes a 1.28-inch HD AMOLED display. Notable features include enhanced GPS tracking with five satellite systems, automatic sport recognition, and continuous health monitoring. Priced at $119.99 in the US and €129.90 in EMEA, the Amazfit GTR Mini is now available at Amazfit stores. This release reinforces Amazfit's commitment to health and fitness technology.
Zepp Health Corporation (NYSE: ZEPP), a leader in smart wearable technology, will report its fourth quarter and full year 2022 unaudited financial results on March 21, 2023, before market opening. A conference call is scheduled for 8:00 a.m. ET on the same day. Participants can access the call via US toll-free number +1-888-346-8982 or international number +1-412-902-4272. The live webcast and archived version will also be available on the company’s investor relations website. This announcement highlights Zepp Health's ongoing commitment to integrate health with technology and its position as a developer of health and fitness devices.
Zepp Health Corporation (NYSE: ZEPP) has announced it will report its third quarter 2022 unaudited financial results before market open on November 21, 2022. Management will conduct a conference call at 7:30 a.m. ET on the same day, accessible via various dialing options for US and international listeners. Additionally, a live and archived webcast will be available on their investor relations website. Zepp Health, previously known as Huami Corp., focuses on integrating health with technology through smart wearable devices and data analytics.